KCell Biosciences
PrivateLast Round
Corporate Funding
Mar 7, 2025
Total Funding Raised
$8.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
KCell Biosciences operates in Healthcare & Life Sciences and is based in Busan. Its latest recorded funding round was a Series A round in July 2022.
KCell Biosciences is a biotechnology company that manufactures serum-free and chemically defined cell culture media for biopharmaceutical and cultivated food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KCell Biosciences Comparables
Compare KCell Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Welgene Inc. | 83% | |
| Defined Bioscience | 81% | |
| Thousand Oaks Biopharmaceuticals | 75% |
For institutional investors. Book with your work email.
KCell Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 7, 2025 | ||||
| Series A | Jul 12, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
KCell Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CKD Venture Capital | Series A |
| DAYLI Partners | Series A |
| Sema Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 33% MoM.
- Jul 26, 2026
Monthly visitors increased 81% MoM.
For institutional investors. Book with your work email.
KCell Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about KCell Biosciences's valuation, stock price, and market status.
Is KCell Biosciences a public or private company?
KCell Biosciences is a private company.
What is the current stock price of KCell Biosciences?
KCell Biosciences is a private company, so its shares have no public market price. Caplight tracks KCell Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is KCell Biosciences worth (valuation)?
Valuation information for KCell Biosciences is not publicly available.
Can I buy KCell Biosciences stock?
KCell Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was KCell Biosciences's last funding round?
KCell Biosciences's most recent funding round was Corporate Funding on March 7, 2025.
Who are the main investors in KCell Biosciences?
Key investors in KCell Biosciences include CKD Venture Capital, DAYLI Partners, Sema Investment.
Will KCell Biosciences IPO soon?
No public IPO plans have been announced for KCell Biosciences.
How can I track KCell Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in KCell Biosciences's shares on secondary markets.